| 1 | LLY | Eli Lilly and Company | 18.71% |
| 2 | NVSN.MX | Novartis AG ADR | 11.39% |
| 3 | MRK | Merck & Co., Inc. | 9.56% |
| 4 | BMY | Bristol-Myers Squibb Company | 4.97% |
| 5 | PFE | Pfizer Inc. | 4.92% |
| 6 | JNJ | Johnson & Johnson | 4.92% |
| 7 | NVO | Novo Nordisk A/S | 4.78% |
| 8 | MCK | McKesson Corporation | 4.77% |
| 9 | GSK | GSK plc | 4.76% |
| 10 | LON: AZN | AstraZeneca PLC | 4.46% |
| 11 | ABBV | AbbVie Inc. | 4.32% |
| 12 | COR | Cencora, Inc. | 4.11% |
| 13 | SNY | Sanofi | 3.90% |
| 14 | ZTS | Zoetis Inc. | 3.28% |
| 15 | HLN | Haleon plc | 2.98% |
| 16 | TAK | Takeda Pharmaceutical Company Limited | 2.89% |
| 17 | TEVA | Teva Pharmaceutical Industries Limited | 2.53% |
| 18 | VTRS | Viatris Inc. | 0.83% |
| 19 | JAZZ | Jazz Pharmaceuticals plc | 0.66% |
| 20 | ELAN | Elanco Animal Health Incorporated | 0.43% |
| 21 | AXSM | Axsome Therapeutics, Inc. | 0.43% |
| 22 | CORT | Corcept Therapeutics Incorporated | 0.16% |
| 23 | OGN | Organon & Co. | 0.10% |
| 24 | TSX: BHC | Bausch Health Companies Inc. | 0.08% |
| 25 | PRGO | Perrigo Company plc | 0.06% |
| View PPH holdings |
